Antiverse

About:

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Top Investors: Future Planet Capital, SyndicateRoom, AngelHub, Tensor Ventures, UK Innovation & Science Seed Fund

Description:

Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.

Total Funding Amount:

7.76M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cardiff, Cardiff, United Kingdom

Founded Date:

2017-04-01

Contact Email:

info(AT)antiverse.io

Founders:

Ben Holland, Murat Tunaboylu, Rowina Westermeier

Number of Employees:

11-50

Last Funding Date:

2024-10-15

IPO Status:

Private

Industries: